![Marc Bozec](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Bozec
Director Ejecutivo en
OSE IMMUNOTHERAPEUTICS
.
Perfil
Marc Le Bozec is the founder of BioProtein Technologies SA, founded in 1998.
Mr. Bozec is currently the Chief Executive Officer at OSE Immunotherapeutics SA since 2025 and an Independent Director at Nicox SA since 2024.
Formerly, Director at CYTOO SA from 2013 to 2015.
Education includes an undergraduate degree from École des Hautes Études Commerciales de Paris.
Cargos activos de Marc Bozec
| Empresas | Cargo | Inicio |
|---|---|---|
| NICOX SA | Director/Miembro de la Junta | 16/07/2024 |
| OSE IMMUNOTHERAPEUTICS | Director Ejecutivo | 02/10/2025 |
Antiguos cargos conocidos de Marc Bozec.
| Empresas | Cargo | Fin |
|---|---|---|
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Director/Miembro de la Junta | 01/01/2015 |
BioProtein Technologies SA
 BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines | Fundador | - |
Formación de Marc Bozec.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
10
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
BioProtein Technologies SA
BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Health Technology |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
- Bolsa de valores
- Insiders
- Marc Bozec
